Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Plos One|August 10, 2018
Diagnostic value of partial exome sequencing in developmental disordersLaura Gieldon, Luisa Mackenroth, Anne-Karin Kahlert, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 28, 2018
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paragangliomaSusan Richter, Laura Gieldon, Ying Pang, et al.
Cancers|June 20, 2019
Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research ApproachesLaura Gieldon, Doreen William, Karl Hackmann, et al.
Cold Spring Harbor Molecular Case Studies|March 6, 2019
Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistancePeter Horak, Joachim Weischenfeldt, Gunhild von Amsberg, et al.
Genes, Chromosomes & Cancer|July 31, 2021
Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicinePeter Horak, Jonas Leichsenring, Hannah Goldschmid, et al.
The Journal of Clinical Investigation|February 5, 2020
Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumorsMichael W Ronellenfitsch, Patrick N Harter, Martina Kirchner, et al.
Cancer Research|August 10, 2017
ATM Deficiency Generating Genomic Instability Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Therapy-Induced DNA DamageLukas Perkhofer, Anna Schmitt, Maria Carolina Romero Carrasco, et al.
Endocrinology|July 20, 2019
Synergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor CulturesMaria Fankhauser, Nicole Bechmann, Michael Lauseker, et al.
Genes, Chromosomes & Cancer|June 6, 2020
Germline SDHB-inactivating mutation in gastric spindle cell sarcomaChristoph E Heilig, Peter Horak, Daniel B Lipka, et al.
JCO Precision Oncology|May 26, 2021
CATCH: A Prospective Precision Oncology Trial in Metastatic Breast CancerMario Hlevnjak, Markus Schulze, Shaymaa Elgaafary, et al.
Pageof 3